干擾素γ誘導(dǎo)單核因子(MIg)多克隆抗體
Polyclonal Antibody to Monokine Induced By Interferon Gamma (MIg)
CXCL9; CMK; Humig; MI-G; SCYB9; Crg-10; Chemokine (C-X-C motif) ligand 9; Small-inducible cytokine B9; Gamma-interferon-induced monokine
- 編號(hào)PAB928Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來(lái)源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原 RPB928Hu01-干擾素γ誘導(dǎo)單核因子(MIg)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 418 ¥ 974 ¥ 1392 ¥ 3480 ¥ 13920
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Western Blot; Sample: Recombinant MIg,Human.
-
Western Blot; Samples: Lane1: THP1 treated with 200ng/ml IFNγ and 50ng/ml LPS for 24 hours, cell precipitation; Lane2: Untreated THP1 cell lysate;
Primary Ab: 0.3μg/ml Rabbit Anti-Human MIg Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Samples: Lane1: A431 treated with 200ng/ml IFNγ and 50ng/ml LPS for 24 hours, cell precipitation; Lane2: Untreated A431 cell lysate;
Primary Ab: 0.3μg/ml Rabbit Anti-Human MIg Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)MIg的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別MIg。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APB928Hu01 | 干擾素γ誘導(dǎo)單核因子(MIg)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPB928Hu02 | 干擾素γ誘導(dǎo)單核因子(MIg)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB928Hu01 | 干擾素γ誘導(dǎo)單核因子(MIg)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB928Hu01 | 干擾素γ誘導(dǎo)單核因子(MIg)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB928Hu02 | 干擾素γ誘導(dǎo)單核因子(MIg)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB928Hu81 | 干擾素γ誘導(dǎo)單核因子(MIg)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB928Hu71 | 干擾素γ誘導(dǎo)單核因子(MIg)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| FAB928Hu51 | 抗干擾素γ誘導(dǎo)單核因子(MIg)多克隆抗體(別藻藍(lán)蛋白標(biāo)記) | FCM |
| MAB928Hu22 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB928Hu21 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB,IHC |
| MAB928Hu23 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB928Hu24 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB928Hu25 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB928Hu27 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB928Hu29 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB |
| MAB928Hu26 | 干擾素γ誘導(dǎo)單核因子(MIg)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB928Hu | 干擾素γ誘導(dǎo)單核因子(MIg)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB928Hu | 干擾素γ誘導(dǎo)單核因子(MIg)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB928Hu | 干擾素γ誘導(dǎo)單核因子(MIg)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB928Hu01 | 干擾素γ誘導(dǎo)單核因子(MIg)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| PLoS One. | The Transcription Factor C/EBP delta Has Anti-Apoptotic and Anti-Inflammatory Roles in Pancreatic Beta Cells [PubMed: PMC3275575] |
| International Journal of Chronic Obstructive Pulmonary Disease | High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease [33814903] |
